Sep 2026· Biotechnology and Bioengineering· 0 citations· 29 references
Medicine
Abstract
The biocatalytic asymmetric amination of bulky N-heterocyclic ketones is often limited by low enzyme activity and poor performance at high substrate loading. Herein, we developed an efficient (R)-selective transaminase for the synthesis of (R)-1-Boc-3-aminopiperidine through an integrated strategy combining phylogeny-guided enzyme mining, structure-guided engineering, and mechanistic analysis. Screening of transaminases identified MbATA as the "best" parent enzyme, affording the target amine from N-Boc-3-piperidone (1B3OP) in specific activities of 0.269 U·g-1 and > 99% ee. Subsequent engineering yielded variant M3 (H61L/Q57R/P158Q), which exhibited a 45-fold increase in activity over the wild type (WT) while retaining strict enantioselectivity (> 99% ee). M3 achieved completely aminated 500 mM substrate loading within 4 h, 1000 mM in an extended duration of 24 h. Preparative biotransformation afforded 8.5 g and 15.6 g of product in 85% and 78% isolated yields, respectively. Structural and mechanistic analyses showed that the beneficial mutations enlarged and remodeled the substrate-binding pocket, strengthened favorable substrate interactions, shortened the reactive cofactor-substrate distance, and promoted productive binding conformations. These results establish M3 as a practical biocatalyst for high-substrate-loading synthesis of chiral piperidine amines.
(R)-Selective ω-transaminases are valuable biocatalysts for the synthesis of chiral amines and pharmaceutical intermediates, but their practical application is often limited by insufficient catalytic efficiency, poor operational stability and unfavorable reaction equilibrium. Here, an Actinomycete-derived (R)-selective...
Xin-Yu Lu, Feng Guo, Cao-Kai Zhu et al.· International Journal of Bio...· 0 citations
ω-Transaminases (ω-TAs) provide an efficient route to the asymmetric synthesis of chiral amines. However, the intrinsic steric constraints of native ω-TA active sites lead to extremely low or undetectable catalytic activity toward bulky aryl-alkyl substrates. Here, we combined a substrate-truncation strategy with semi-...
Meng Xu, Lin Yang, Guang-Yu Lin et al.· Bioorganic chemistry (Print)· 0 citations
Chiral arylvinyl-substituted 3-hydroxy-5-oxo esters are valuable motifs in pharmaceuticals, yet their enantiocontrolled synthesis remains challenging. Herein, we report a biocatalytic system using ketoreductases (KREDs) for the highly C3-selective reduction of arylvinyl-substituted 3,5-dicarbonyl esters. Through semira...
Xiao-Qiu Wu, Ming-Yu Zhang, Ming-Yang Yao et al.· Organic Letters· 0 citations
The direct asymmetric synthesis of chiral amides remains a focal point in green manufacturing, particularly for (S)-2-aminobutyramide whose traditional production is often hampered by low atom economy and arduous chiral resolution steps. Here, we report the creation of a non-native bio-amidation activity in Escherichia...
Qianpeng Lai, Yi-Wei Meng, Zhong-Mei Liu et al.· Chemical Science· 0 citations
R reverse screening as an effective approach for evolving transaminases toward sterically hindered substrates is validates reverse screening as an effective approach for evolving transaminases toward sterically hindered substrates and highlights RTA-223 as a promising candidate for further biocatalyst development.
Matthew Treadell, Gareth R E Surman, G. Ford et al.· RSC Chemical Biology· 0 citations